Ni J - Search Results

1

Management of immune checkpoint inhibitor-related adverse events: A review of case reports.

Si X, Song P, Ni J, Di M, He C, Zhang L, Liu X, Li Y, Wang H, Guo X, Zhou J, Duan L, Yang X, Wang M, Zhang L. Si X, et al. Among authors: ni j. Thorac Cancer. 2020 Mar;11(3):498-504. doi: 10.1111/1759-7714.13315. Epub 2020 Jan 22. Thorac Cancer. 2020. PMID: 31970923 Free PMC article. Review.

2

Regulation of MEIS1 by distal enhancer elements in acute leukemia.

Wang QF, Li YJ, Dong JF, Li B, Kaberlein JJ, Zhang L, Arimura FE, Luo RT, Ni J, He F, Wu J, Mattison R, Zhou J, Wang CZ, Prabhakar S, Nobrega MA, Thirman MJ. Wang QF, et al. Among authors: ni j. Leukemia. 2014 Jan;28(1):138-46. doi: 10.1038/leu.2013.260. Epub 2013 Sep 11. Leukemia. 2014. PMID: 24022755 Free PMC article.

3

[The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].

Ni J, Guo Z, Zhang L. Ni J, et al. Zhonghua Nei Ke Za Zhi. 2016 Jan;55(1):25-30. doi: 10.3760/cma.j.issn.0578-1426.2016.01.007. Zhonghua Nei Ke Za Zhi. 2016. PMID: 26796649 Chinese.

4

Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer.

Ni J, Zhang L. Ni J, et al. Chin Med J (Engl). 2016 Feb 5;129(3):332-40. doi: 10.4103/0366-6999.174484. Chin Med J (Engl). 2016. PMID: 26831237 Free PMC article. Review.

5

Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.

Yang D, Zhang X, Powell CA, Ni J, Wang B, Zhang J, Zhang Y, Wang L, Xu Z, Zhang L, Wu G, Song Y, Tian W, Hu JA, Zhang Y, Hu J, Hong Q, Song Y, Zhou J, Bai C. Yang D, et al. Among authors: ni j. Cancer. 2018 Jan 15;124(2):262-270. doi: 10.1002/cncr.31020. Epub 2017 Sep 20. Cancer. 2018. PMID: 28940455 Free article.

6

Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy.

Ni J, Zhang L, Zhang X. Ni J, et al. Eur J Cancer. 2020 Mar;128:57-59. doi: 10.1016/j.ejca.2019.12.030. Epub 2020 Mar 5. Eur J Cancer. 2020. PMID: 32109851 No abstract available.

7

Opportunistic bowel infection after corticosteroid dosage tapering in a stage IV lung cancer patient with tislelizumab-related colitis.

Ni J, Zhang X, Zhang L. Ni J, et al. Thorac Cancer. 2020 Jun;11(6):1699-1702. doi: 10.1111/1759-7714.13401. Epub 2020 Apr 2. Thorac Cancer. 2020. PMID: 32239681 Free PMC article.

8

Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non-small-cell lung cancer and ERBB2 mutation.

Wu Y, Ni J, Chang X, Zhang X, Zhang L. Wu Y, et al. Among authors: ni j. Thorac Cancer. 2020 Jul;11(7):2051-2055. doi: 10.1111/1759-7714.13480. Epub 2020 May 26. Thorac Cancer. 2020. PMID: 32458584 Free PMC article.

9

Cancer Cachexia: Definition, Staging, and Emerging Treatments.

Ni J, Zhang L. Ni J, et al. Cancer Manag Res. 2020 Jul 9;12:5597-5605. doi: 10.2147/CMAR.S261585. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753972 Free PMC article. Review.

10

[Progress of immunotherapy-related adverse events].

Ni J, Zhang L. Ni J, et al. Zhonghua Nei Ke Za Zhi. 2021 Jan 1;60(1):84-89. doi: 10.3760/cma.j.cn112138-20200308-00204. Zhonghua Nei Ke Za Zhi. 2021. PMID: 33397030 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,740 results

Search Page